Bronchiectasis, an Issue of Clinics in Chest Medicine
The first issue of Clinics in Chest Medicine to be published with this focus, this issue reviews bronchiectasis from numerous angles to provide comprehensive coverage on this important subject. Epidemiology, airway defense mechanisms, pathogenesis, imaging and genetic causes of bronchiectasis are discussed. Allergic bronchopulmonary aspergillosis is addressed, as well as non-tuberculous mycobacteria as a cause of bronchiectasis. Authors examine how to evaluate the success of therapy for bronchiectasis (what endpoints to use) and then discuss a variety of therapy options: inhaled and systemic antibiotic treatment, chest physiotherapy, pharmacologic agents for mucous clearance, antipinflammatory therapy and macrolides. Pulmonary resection and lung transplantation for bronchiectasis are reviewed. Recent advances in Cystic Fibrosis are also discussed.
What people are saying - Write a review
We haven't found any reviews in the usual places.
CLINICS IN CHEST MEDICINE
Chapter 1 Airway Defense Mechanisms
Chapter 2 Pathogenesis of Bronchiectasis
Chapter 3 The Initial Evaluation of Adults with Bronchiectasis
Chapter 4 Imaging of Bronchiectasis
Chapter 5 Genetic Causes of Bronchiectasis
Chapter 6 Allergic Bronchopulmonary Aspergillosis
Chapter 10 Recent Advances in Cystic Fibrosis
Chapter 11 Evaluating Success of Therapy for Bronchiectasis What End Points to Use?
Chapter 12 Chest Physiotherapy Techniques in Bronchiectasis
Chapter 13 Pharmacologic Agents for Mucus Clearance in Bronchiectasis
Chapter 15 The Use of Antiinflammatory Therapy and Macrolides in Bronchiectasis
Chapter 16 Antimicrobial Therapy for Bronchiectasis
Chapter 17 Pulmonary Resection and Lung Transplantation for Bronchiectasis
Chapter 8 Bronchiectasis and Nontuberculous Mycobacterial Disease
Chapter 9 Diffuse Panbronchiolitis
Other editions - View all
abnormalities ABPA ACBT activity adults agents airway airway inflammation allergic bronchopulmonary aspergillosis antibiotic assess associated asthma azithromycin bacterial Between-group comparison biofilm bron bronchi bronchial bronchiec cause CFTR mutations Chest chiectasis chronic Clin clinical cough cystic fibrosis deficiency diagnosis diffuse panbronchiolitis ectasis effects erythromycin evaluation exacerbations factors FEV1 fibrosis bronchiectasis fluticasone gene genetic high-resolution HRCT images immune Immunol improvement increased infection inflammatory inhaled corticosteroids lobe lung function macrolide macrolide therapy macrophages mannitol markers ment mucociliary clearance mucus Mycobacterium nebulized neutrophil non-CF bronchiectasis non-cystic fibrosis nontuberculous NTM lung disease obstruction oral outcomes pathogens patients with bronchiectasis patients with CF patients with cystic phenotype physiotherapy placebo potential primary ciliary dyskinesia protein Pseudomonas aeruginosa radiographic randomized controlled trial reported resection Respir Crit respiratory response role saline secretions serum significant specific sputum sputum volume suggest symptoms syndrome tasis techniques testing Thorax tion tobramycin treatment